RET and cancer: Tyrosine kinase inhibitors of ALK and RET, the principle of action is to inhibit the phosphorylation of ALK and the activation of signaling proteins, and can continuously inhibit the proliferation of cancer cells and the mutation of ALK, and eventually slow down the progression of cancer